Wellington Management Group LLP Karyopharm Therapeutics Inc. Transaction History

Wellington Management Group LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $586,672 - $1.5 Million	327,750 Added 140.03%	561,799 $1.01 Million
Q1 2023 May 12, 2023	BUY	$2.84 - $3.92 $15,421 - $21,285	5,430 Added 2.38%	234,049 $910,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $5.93 $40,957 - $97,933	-16,515 Reduced 6.74%	228,619 $777,000
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $199,071 - $283,969	48,792 Added 24.85%	245,134 $1.34 Million
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $30,779 - $74,891	-5,208 Reduced 2.58%	196,342 $1.45 Million
Q4 2021 Feb 11, 2022	BUY	$5.21 - $8.61 $1.05 Million - $1.74 Million	201,550 New	201,550 $1.3 Million
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $2.65 Million - $6.34 Million	-596,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $10.7 Million - $14.7 Million	-1,321,768 Reduced 68.92%	596,000 $6.15 Million
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $2.58 Million - $4.62 Million	-261,447 Reduced 12.0%	1,917,768 $20.2 Million
Q4 2020 Feb 12, 2021	BUY	$14.15 - $17.19 $6.18 Million - $7.5 Million	436,515 Added 25.05%	2,179,215 $33.7 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $3.4 Million - $4.73 Million	240,199 Added 15.99%	1,742,700 $25.4 Million
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $1.72 Million - $2.62 Million	103,855 Added 7.43%	1,502,501 $28.5 Million
Q1 2020 May 14, 2020	BUY	$14.38 - $27.72 $575,430 - $1.11 Million	40,016 Added 2.95%	1,398,646 $26.9 Million
Q4 2019 Feb 11, 2020	BUY	$9.23 - $19.67 $12.5 Million - $26.7 Million	1,358,630 New	1,358,630 $26 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $55.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.